Impact of patients’ refusal to undergo adjuvant treatment measures on survival

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021820

Enrollment

4315

Registered

2020-05-27

Start date

2020-05-19

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C50.9

Interventions

Group 1: Retrospective registration of patients with primary diagnosis of breast cancer who were treated at the Ortenau-Klinikum Offenburg-Kehl Breast Center between 1/1997 and 12/2019.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with primary diagnosis of breast cancer who were treated at the Ortenau-Klinikum Offenburg-Kehl Breast Center between 1/1997 and 12/2019.

Exclusion criteria

Exclusion criteria: Non primary cases, e.g. through treatment in another hospital. Primary palliative cases.

Design outcomes

Primary

Measure	Time frame
Presentation of survival data and recurrence-free survival depending on the acceptance or rejection of the tumor board recommendation.	—

Secondary

Measure	Time frame
Patient and / or disease characteristics associated with rejection of the tumor board recommendation.	—

Countries

Germany

Contacts

Public ContactHeidrun Männle

Ortenau-Klinikum Offenburg-Kehl

heidrun.maennle@ortenau-klinikum.de0781/472-3501

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026